A Double-blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression.
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2015
At a glance
- Drugs Cariprazine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 06 Nov 2015 Results published online in the American Journal of Psychiatry.
- 20 May 2015 Results presented at the 168th Annual Meeting of the American Psychiatric Association.
- 31 Mar 2014 Results have been reported in a Forest Laboratories and Gedeon Richter media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History